KALA BIO
KALA
68 hedge funds and large institutions have $196M invested in KALA BIO in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 8 closing their positions.
74% more capital invested
Capital invested by funds: $112M → $196M (+$83.5M)
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
6% more funds holding
Funds holding: 64 → 68 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more ownership
Funds ownership: 0.03% → 0.03% (+0%)
96% less call options, than puts
Call options by funds: $7K | Put options by funds: $197K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.58M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.95M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.22M |
| 4 |
TA
Teachers Advisors
New York
|
+$1.15M |
| 5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$1.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.78M |
| 2 |
BC
Broadfin Capital
New York
|
-$1.66M |
| 3 |
Renaissance Technologies
New York
|
-$1.28M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.05M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$711K |
KALA Hedge Fund Activity: Q1 2019 in Review
68 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2019, worth a combined $196M — up 74% from $112M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new KALA positions and 8 closed out — a net gain of 4 holders — while 18 added to existing stakes and 16 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.58M. The largest seller was Deutsche Bank, cutting an estimated $1.78M.
- 68 institutional investors held KALA BIO (KALA) as of Q1 2019, up from 64 in Q4 2018.
- Funds reported $196M of KALA BIO stock for Q1 2019, up 74% quarter-over-quarter.
- 12 funds opened new KALA BIO positions in Q1 2019 and 8 closed out, a net change of +4 holders.
- The largest KALA BIO buyer in Q1 2019 was Millennium Management, an estimated $4.58M added.
- The largest KALA BIO seller in Q1 2019 was Deutsche Bank, an estimated $1.78M sold.
Based on aggregated 13F filings for Q1 2019.